TuesdayDec 20, 2022 3:25 pm

TinyGemsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Begins Dosing in Its Human Oral Nicotine Study

Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug delivery platforms, today announced that dosing has begun in its human clinical nicotine study NIC-H22-1. Current cigarette smokers are participating in the 36-person human pharmacokinetic randomized, double blinded, cross-over study, wherein each person will visit the laboratory to be dosed three times over the coming weeks. Only one oral nicotine pouch (DehydraTECH-nicotine, On! brand manufactured by Altria, or Zyn brand manufactured by Swedish Match) will be administered and evaluated during each visit. The primary objectives are to determine the quantity of nicotine in blood at various time points and collection…

Continue Reading

TuesdayDec 20, 2022 12:08 pm

TinyGemsBreaks – Cepton Inc. (NASDAQ: CPTN) to Participate in 21st Annual J.P. Morgan Tech/Auto Forum

Cepton (NASDAQ: CPTN), a Silicon Valley innovator and leader in high-performance lidar solutions, today announced that its Chief Executive Officer Dr. Jun Pei and Chief Financial Officer Hull Xu will be participating in the 21st Annual J.P. Morgan Tech/Auto Forum. The forum is slated to take place at the Bellagio Hotel during CES 2023 in Las Vegas, Nevada, on Jan. 5, 2023. Cepton will participate in a fireside chat at the event at 2:20 p.m. PT on Thursday, Jan. 5. Interested parties should visit https://ibn.fm/2Sfvm to view a live audio webcast of the presentation. To view the full press release,…

Continue Reading

TuesdayDec 20, 2022 11:37 am

TinyGemsBreaks — Mullen Automotive Inc. (NASDAQ: MULN) Wraps Up 2022 Mullen FIVE Strikingly Different Tour

Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, finished its innovative 2022 Mullen FIVE Strikingly Different Test Drive Tour with a last stop on Dec. 16, 2022, in Charlotte, North Carolina. The tour began Oct. 27, 2022, and featured stops in nine cities in the west, south, and southeastern parts of the country. According to the announcement, the tour was very successful; the company is already planning a follow-up spring tour with stops planned throughout the eastern, northwest and Midwest parts of the country. The fall tour featured the Mullen Five; the spring tour will feature the Mullen…

Continue Reading

TuesdayDec 20, 2022 11:12 am

TinyGemsBreaks – Cybin Inc. (NYSE American: CYBN) (NEO: CYBN) CEO Highlights 2022 as ‘Momentous Year’

Cybin (NYSE American: CYBN) (NEO: CYBN), a biopharmaceutical company focused on progressing Psychedelics to Therapeutics(R), today issued a year-end summary of its key milestone accomplishments in 2022. “2022 was a momentous year marked by steady progress across our pipeline of differentiated psychedelic-based therapeutics and partnerships targeting mental health. Most notable were the advancements of our two lead programs, CYB003 and CYB004, into clinical stage – within less than 18 months since discovery – which is a remarkable accomplishment and a true testament to the strength of our team,” said Cybin’s Chief Executive Officer Doug Drysdale. “Along with our clinical programs,…

Continue Reading

FridayDec 16, 2022 3:18 pm

TinyGemsBreaks – Lexaria Bioscience Corp.’s (NASDAQ: LEXX) DehydraTECH(TM)-CBD Expected to Yield Notable Results in Diabetes Study

Lexaria Bioscience Corp. (NASDAQ: LEXX) is a global leader in enhancing the speed and efficiency of orally delivered fat-soluble active molecules and drugs. “Lexaria [recently] announced that the study program DIAB-A22-1 [had begun] on schedule, making it the company’s first-ever study to investigate whether its DehydraTECH-processed cannabidiol (‘CBD’) may potentially have therapeutic utility against diabetes,” a recent article reads. “Lexaria is optimistic that its DehydraTECH-CBD will yield notable results from this study, especially having met primary safety and efficacy objectives from its HYPER-H21-4 clinical study. There is a strong connection between heart disease, hypertension and diabetes, with hypertension proving to…

Continue Reading

FridayDec 16, 2022 11:11 am

TinyGemsBreaks – Energy Fuels Inc. (NYSE American: UUUU) (TSX: EFR) to Contribute to Domestic Energy Security, Supply U308 to US Uranium Reserve

Energy Fuels (NYSE American: UUUU) (TSX: EFR), a leading U.S. producer of uranium and rare earth elements (“REE”), today announced that it has been awarded a contract to sell $18.5 million of natural uranium concentrates (“U3O8”) to the U.S. government for the establishment of a strategic “Uranium Reserve.” The U.S. National Nuclear Security Administration (“NNSA”), an office within the U.S. Department of Energy (“DOE”), is tasked with purchasing domestic U3O8 and conversion services for the Uranium Reserve, intended as a backup source of supply for domestic nuclear power plants in the event of a significant market disruption. “Energy Fuels is…

Continue Reading

FridayDec 16, 2022 10:21 am

TinyGemsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Shares Annual General Meeting Results

InMed Pharmaceuticals (NASDAQ: INM), a leader in the pharmaceutical research, development and manufacturing of rare cannabinoids and cannabinoid analogs, is reporting on the results of its 2022 annual meeting. The meeting of shareholders was held Dec. 15, 2022. During the meeting, shareholders considered and voted on all matters outlined in InMed’s notice of meeting and management information circular. Specifically, the election of directors was held, and shareholders approved the election of all director nominees to hold office until the next annual meeting of shareholders. Those directors included Eric Adams, Andrew Hull, Janet Grove, Bryan Baldasare, and Nicole Lemerond. To view…

Continue Reading

ThursdayDec 15, 2022 3:51 pm

TinyGemsBreaks – MICT Inc. (NASDAQ: MICT) Regains Compliance with Nasdaq Listing Requirements

MICT (NASDAQ: MICT), which recently acquired the operating business and assets of Tingo (OTC: TMNA) (“Tingo Mobile Limited” or “Tingo Mobile”), announced that it has received a bid price compliance letter from the Nasdaq Stock Market LLC. The letter informs MICT that it has regained compliance with the minimum bid price requirement under Nasdaq Listing Rule 5550(a)(2) for continued listing on the Nasdaq. MICT was previously notified that it was not in compliance with the rule due to its common stock failing to meet the closing bid price of $1.00 or more for 30 consecutive business days. To regain compliance,…

Continue Reading

ThursdayDec 15, 2022 3:09 pm

TinyGemsBreaks – Knightscope, Inc. (NASDAQ: KSCP) Announces New ASR Deployment to One of Nation’s Largest Parking Service Providers

Knightscope (NASDAQ: KSCP), a developer of advanced physical monitoring technologies focused on enhancing U.S. facility operations, has partnered with ABM Industries Inc. (NYSE: ABM) to provide surveillance and security at an international airport parking facility. ABM is one of the nation’s largest parking service providers; the company has built a reputation as a leading provider of integrated facility services, parking and transportation management solutions, as well as electric vehicle (“EV”) charger installations. As part of the partnership, Knightscope is introducing innovative new automated monitoring measure and parking infrastructure improvements. According to the announcement, Knightscope Autonomous Security Robots (“ASRs”) will navigate and monitor…

Continue Reading

ThursdayDec 15, 2022 12:36 pm

TinyGemsBreaks — Mullen Automotive Inc. (NASDAQ: MULN) Announces New PO for 6,000 Class 1 EV Cargo Vans

Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, received a purchase order for 6,000 Class 1 EV cargo vans; the order comes from Randy Marion Isuzu LLC, a member of the Randy Marion Automotive Group (“RMA”). According to the announcement, the order is valued at an estimated $200 million, and MULN anticipates starting delivery of the vehicles by Q1 2023. One of the largest and most respected commercial vehicle dealer groups in the United States, RMA was announced as Mullen’s first commercial dealer partner to offer sales, service and parts for Mullen Automotive’s commercial vehicle lineup. An RMA…

Continue Reading

Contact us: (512) 354-7000